JP2024530839A5 - - Google Patents

Info

Publication number
JP2024530839A5
JP2024530839A5 JP2023578030A JP2023578030A JP2024530839A5 JP 2024530839 A5 JP2024530839 A5 JP 2024530839A5 JP 2023578030 A JP2023578030 A JP 2023578030A JP 2023578030 A JP2023578030 A JP 2023578030A JP 2024530839 A5 JP2024530839 A5 JP 2024530839A5
Authority
JP
Japan
Prior art keywords
saponin
oligonucleotide complex
oligonucleotide
saponins
complex according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023578030A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024530839A (ja
Filing date
Publication date
Priority claimed from PCT/NL2021/050384 external-priority patent/WO2021261992A1/en
Priority claimed from PCT/NL2021/050549 external-priority patent/WO2022055351A1/en
Application filed filed Critical
Priority claimed from PCT/NL2022/050127 external-priority patent/WO2022265493A1/en
Publication of JP2024530839A publication Critical patent/JP2024530839A/ja
Publication of JP2024530839A5 publication Critical patent/JP2024530839A5/ja
Pending legal-status Critical Current

Links

JP2023578030A 2021-06-18 2022-03-08 サポニン、オリゴヌクレオチド、およびGalNAcの複合体 Pending JP2024530839A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
PCT/NL2021/050384 WO2021261992A1 (en) 2020-06-24 2021-06-18 Conjugate of galnac and saponin, therapeutic composition comprising said conjugate and a galnac-oligonucleotide conjugate
NLPCT/NL2021/050384 2021-06-18
NLPCT/NL2021/050549 2021-09-09
PCT/NL2021/050549 WO2022055351A1 (en) 2020-09-10 2021-09-09 Conjugate of saponin, oligonucleotide and galnac
PCT/NL2022/050127 WO2022265493A1 (en) 2021-06-18 2022-03-08 Conjugate of saponin, oligonucleotide and galnac

Publications (2)

Publication Number Publication Date
JP2024530839A JP2024530839A (ja) 2024-08-26
JP2024530839A5 true JP2024530839A5 (cg-RX-API-DMAC10.html) 2025-03-13

Family

ID=80785160

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023578030A Pending JP2024530839A (ja) 2021-06-18 2022-03-08 サポニン、オリゴヌクレオチド、およびGalNAcの複合体

Country Status (4)

Country Link
US (1) US20240307545A1 (cg-RX-API-DMAC10.html)
EP (2) EP4591938A3 (cg-RX-API-DMAC10.html)
JP (1) JP2024530839A (cg-RX-API-DMAC10.html)
WO (1) WO2022265493A1 (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118356506A (zh) * 2023-01-17 2024-07-19 中国科学院上海药物研究所 去唾液酸糖蛋白受体配体与细胞毒素的偶联物及其应用
GB202300865D0 (en) * 2023-01-20 2023-03-08 Proqr Therapeutics Ii Bv Delivery of oligonucleotides
WO2024235273A1 (zh) * 2023-05-15 2024-11-21 成都社泰医疗科技有限公司 多靶向化合物及其应用
JP2026521777A (ja) * 2023-06-21 2026-07-01 サプリーム テクノロジーズ,ベー.フェー. 中枢神経系障害を処置するための医薬組成物
WO2026087680A1 (en) 2024-10-24 2026-04-30 Sapreme Technologies B.V. Treatment for cardiovascular disease
WO2026087695A1 (en) 2024-10-24 2026-04-30 Sapreme Technologies B.V. Treatment for metabolic disorder
WO2026087678A1 (en) 2024-10-24 2026-04-30 Sapreme Technologies B.V. Treatment for renal disorders
WO2026119464A1 (en) 2024-12-03 2026-06-11 Sapreme Technologies B.V. Treatment for cns-related disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5273965A (en) * 1992-07-02 1993-12-28 Cambridge Biotech Corporation Methods for enhancing drug delivery with modified saponins
CA2522213A1 (en) * 2003-04-08 2004-10-28 Dante J. Marciani Semi-synthetic saponin analogs with carrier and immune stimulatory activities for dna and rna vaccines
WO2011054811A1 (en) * 2009-11-03 2011-05-12 Santaris Pharma A/S Rna antagonists targeting hsp27 combination therapy
KR20160083876A (ko) * 2013-11-14 2016-07-12 로슈 이노베이션 센터 코펜하겐 에이/에스 ApoB 안티센스 접합체 화합물
EP3652190B1 (en) * 2017-07-11 2023-06-14 Freie Universität Berlin Novel uses of a saponin and method for its isolation
US20220023433A1 (en) * 2018-12-21 2022-01-27 Sapreme Technologies B.V. Saponin Conjugates
WO2022055351A1 (en) * 2020-09-10 2022-03-17 Sapreme Technologies B.V. Conjugate of saponin, oligonucleotide and galnac

Similar Documents

Publication Publication Date Title
Kacprzak et al. Alkaloids and isoprenoids modification by copper (I)-catalyzed Huisgen 1, 3-dipolar cycloaddition (click chemistry): Toward new functions and molecular architectures
JP4365221B2 (ja) 親水性ポリマー−マルチカルボキシルオリゴペプチドと薬剤分子との結合生成物、医薬組成物およびその薬学上の使用
Olotu et al. An update on the pharmacological usage of curcumin: has it failed in the drug discovery pipeline?
EP4591938A3 (en) Conjugate of saponin, oligonucleotide and galnac
CN104922141B (zh) 一种用于治疗乙型病毒性肝炎的siRNA组合物
US11485752B2 (en) Modified oligonucleotides and compound that can be used for synthesizing same
Robert Clinical pharmacokinetics of epirubicin
JPH11508565A (ja) サッカリドコンジュゲート
JPH05505941A (ja) オリゴヌクレオチド―輸送剤ジスルフィド結合体
JP2022542075A5 (cg-RX-API-DMAC10.html)
WO2023179463A1 (zh) 阳离子脂质化合物及其制备方法和应用、以及mRNA递送系统
AU2021421161A1 (en) Ligand compounds, conjugates, and applications thereof
JP2023542500A5 (cg-RX-API-DMAC10.html)
CN101229222A (zh) 一种减轻药物心脏毒性的甘草提取物及应用
EP4596052A3 (en) Therapeutic combination of galnac-oligonucleotide conjugate and saponin, and uses thereof
EP4529953A3 (en) Conjugate of saponin, oligonucleotide and galnac
CN101440113B (zh) 秋水仙碱衍生物-胆汁酸偶合物及其医药用途
WO2013117149A1 (zh) 15-苄亚基-14-脱氧-11,12-脱氢穿心莲内酯衍生物在制备保肝及抗丙肝病毒药物中的用途
CN102040516B (zh) 白藜芦醇衍生物及其医药用途
JP5559535B2 (ja) 薬剤をオロチン酸誘導体として投与することで薬剤の組織内濃度を下げる組成物及びその方法
CN105153259A (zh) 以雌甾为母核的2位或16位取代的查耳酮衍生物及其制备方法和用途
JP2001253823A (ja) Hiv遺伝子発現抑制剤
CN115671086B (zh) 5-羟基-1,7-二苯基-3-庚酮在制备预防或治疗肝癌药物中的应用
RU2819894C1 (ru) Лигандные соединения, конъюгаты и их применение
AU2002342304B2 (en) Agent for improving tissue penetration